Artificial Intelligence (AI) In Medical Writing Market Analysis, Precise Outlook And Trends Report 2033

The new report published by The Business Research Company, titled ""Artificial Intelligence (AI) In Medical Writing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the artificial intelligence (AI) in medical writing market size has grown rapidly in recent years. It will grow from $0.79 billion in 2023 to $0.91 billion in 2024 at a compound annual growth rate (CAGR) of 15.2%. The artificial intelligence (AI) in medical writing market size is expected to see rapid growth in the next few years. It will grow to $1.62 billion in 2028 at a compound annual growth rate (CAGR) of 15.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16590&type=smp

Impact Of Increasing Pharmaceutical Demand On AI In Medical Writing
Increasing demand for new pharmaceutical drugs and therapies is expected to propel the growth of artificial intelligence (AI) in the medical writing market going forward. The increasing demand for new pharmaceutical drugs and therapies is driven by the continual need to address unmet medical needs, treat emerging diseases, combat drug resistance, and improve patient outcomes through innovative and more effective treatments. AI in medical writing within the pharmaceutical and drug production sectors enhances efficiency, accuracy, and innovation, contributing to the development of safer and more effective therapies for various medical conditions. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $384,200 million (€340,000 million) in 2022, an increase of approximately 4.95% from 366,267 million (€323,950 million) in 2021. Therefore, increasing demand for new pharmaceutical drugs and therapies will drive the growth of artificial intelligence (AI) in the medical writing market.

AI-Enhanced Medical Drafting Tool For Regulatory And Clinical Documents
Major companies operating in AI in the medical writing market are focused on integrating advanced features such as AI-Powered drafting to enhance efficiency and accuracy in document creation and management for regulatory submissions and medical communications. AI-powered drafting uses artificial intelligence algorithms to automatically generate initial drafts or outlines of documents, leveraging machine learning and natural language processing to assist in content creation tasks. For instance, in June 2024, TrialAssure, a US-based pharmaceutical technology provider, introduced TrialAssure LINK AI 2.0. This enhanced version enables pharmaceutical and biotechnology firms, clinical research organizations, and service providers to efficiently generate regulatory and medical writing documents using AI. The solution automates the creation of diverse clinical and technical documents, spanning from initial drafting to final approval stages, streamlining the entire authoring process.

The artificial intelligence (AI) in medical writing market covered in this report is segmented -

1) By Type: Clinical Writing, Type Writing, Scientific Writing, Other Types
2) By Application: Regulatory Documentation, Automated Literature Review, Language Translation, Pharmacovigilance, Content Modularization
3) By End Use: Medical Devices, Pharmaceutical, Biotechnology, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16590&type=discount

Major companies operating in the artificial intelligence (AI) in medical writing market are International Business Machines Corporation, IQVIA Holdings Inc., Icon PLC, Syneos Health Pvt Ltd, Parexel International Corporation, Veeva Systems, Cactus Communications, Tata Elxsi, Allucent Inc , Certara Inc , Freyr Solutions , Amplity Health, Indegen Limited, MMS Holdings Inc., Jasper AI Inc, Symbiance AI Inc, GenInvo Technologies Pvt. Ltd., Trilogy Writing & Consulting GmbH, Yseop S.A.S., Turacoz Healthcare Solution, Averbis GmbH, EMTEX Life Sciences, DeepCura AI, Dezzai Inc , Narrativa Inc

Contents of the report:
1. Executive Summary
2. Artificial Intelligence (AI) In Medical Writing Market Report Structure
3. Artificial Intelligence (AI) In Medical Writing Market Trends And Strategies
4. Artificial Intelligence (AI) In Medical Writing Market - Macro Economic Scenario
5. Artificial Intelligence (AI) In Medical Writing Market Size And Growth
…..
27. Artificial Intelligence (AI) In Medical Writing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-medical-writing-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.